INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
OM

Otero Jose Manuel

Chief Technical OfficerCIK 0002024096

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells0 / 5
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A$5,579
2,110 sh
Sep 14, 2026Sep 28, 2026
traded Sep 14, 2026
+14dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Lexeo Therapeutics, Inc.Chief Technical Officer · Nov 20, 2025
5
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A
—
54.8K sh
Sep 24, 2026
Sep 28, 2026
traded Sep 24, 2026
+4d
SEC FORM 4

Evidence

27
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$6,464
1,304 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC FORM 4

Evidence

9
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
12.1K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC FORM 4

Evidence

32
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,666 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC FORM 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$6,606
1,302 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

5
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A$16K
5,930 sh
Mar 13, 2026Mar 17, 2026
traded Mar 13, 2026
+4dSEC FORM 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$19K
3,016 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

5
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
260.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

17
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
65.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

36
OM
Otero Jose ManuelChief Technical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$6,684
721 sh
Aug 18, 2025Nov 20, 2025
traded Aug 18, 2025
+94dSEC FORM 4

Evidence